List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Biological Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Biological Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Biological Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Biological Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Biological Drugs Industry Impact
Chapter 2 Global Biological Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biological Drugs (Volume and Value) by Type
2.1.1 Global Biological Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Biological Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Biological Drugs (Volume and Value) by Application
2.2.1 Global Biological Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Biological Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Biological Drugs (Volume and Value) by Regions
2.3.1 Global Biological Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Biological Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biological Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Biological Drugs Consumption by Regions (2016-2021)
4.2 North America Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Biological Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Biological Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Biological Drugs Market Analysis
5.1 North America Biological Drugs Consumption and Value Analysis
5.1.1 North America Biological Drugs Market Under COVID-19
5.2 North America Biological Drugs Consumption Volume by Types
5.3 North America Biological Drugs Consumption Structure by Application
5.4 North America Biological Drugs Consumption by Top Countries
5.4.1 United States Biological Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Biological Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Biological Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Biological Drugs Market Analysis
6.1 East Asia Biological Drugs Consumption and Value Analysis
6.1.1 East Asia Biological Drugs Market Under COVID-19
6.2 East Asia Biological Drugs Consumption Volume by Types
6.3 East Asia Biological Drugs Consumption Structure by Application
6.4 East Asia Biological Drugs Consumption by Top Countries
6.4.1 China Biological Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Biological Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Biological Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Biological Drugs Market Analysis
7.1 Europe Biological Drugs Consumption and Value Analysis
7.1.1 Europe Biological Drugs Market Under COVID-19
7.2 Europe Biological Drugs Consumption Volume by Types
7.3 Europe Biological Drugs Consumption Structure by Application
7.4 Europe Biological Drugs Consumption by Top Countries
7.4.1 Germany Biological Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Biological Drugs Consumption Volume from 2016 to 2021
7.4.3 France Biological Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Biological Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Biological Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Biological Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Biological Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Biological Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Biological Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Biological Drugs Market Analysis
8.1 South Asia Biological Drugs Consumption and Value Analysis
8.1.1 South Asia Biological Drugs Market Under COVID-19
8.2 South Asia Biological Drugs Consumption Volume by Types
8.3 South Asia Biological Drugs Consumption Structure by Application
8.4 South Asia Biological Drugs Consumption by Top Countries
8.4.1 India Biological Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Biological Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Biological Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Biological Drugs Market Analysis
9.1 Southeast Asia Biological Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Biological Drugs Market Under COVID-19
9.2 Southeast Asia Biological Drugs Consumption Volume by Types
9.3 Southeast Asia Biological Drugs Consumption Structure by Application
9.4 Southeast Asia Biological Drugs Consumption by Top Countries
9.4.1 Indonesia Biological Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Biological Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Biological Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Biological Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Biological Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Biological Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Biological Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Biological Drugs Market Analysis
10.1 Middle East Biological Drugs Consumption and Value Analysis
10.1.1 Middle East Biological Drugs Market Under COVID-19
10.2 Middle East Biological Drugs Consumption Volume by Types
10.3 Middle East Biological Drugs Consumption Structure by Application
10.4 Middle East Biological Drugs Consumption by Top Countries
10.4.1 Turkey Biological Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Biological Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Biological Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Biological Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Biological Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Biological Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Biological Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Biological Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Biological Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Biological Drugs Market Analysis
11.1 Africa Biological Drugs Consumption and Value Analysis
11.1.1 Africa Biological Drugs Market Under COVID-19
11.2 Africa Biological Drugs Consumption Volume by Types
11.3 Africa Biological Drugs Consumption Structure by Application
11.4 Africa Biological Drugs Consumption by Top Countries
11.4.1 Nigeria Biological Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Biological Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Biological Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Biological Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Biological Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Biological Drugs Market Analysis
12.1 Oceania Biological Drugs Consumption and Value Analysis
12.2 Oceania Biological Drugs Consumption Volume by Types
12.3 Oceania Biological Drugs Consumption Structure by Application
12.4 Oceania Biological Drugs Consumption by Top Countries
12.4.1 Australia Biological Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Biological Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Biological Drugs Market Analysis
13.1 South America Biological Drugs Consumption and Value Analysis
13.1.1 South America Biological Drugs Market Under COVID-19
13.2 South America Biological Drugs Consumption Volume by Types
13.3 South America Biological Drugs Consumption Structure by Application
13.4 South America Biological Drugs Consumption Volume by Major Countries
13.4.1 Brazil Biological Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Biological Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Biological Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Biological Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Biological Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Biological Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Biological Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Biological Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Biological Drugs Business
14.1 Bristol-Myers Squibb
14.1.1 Bristol-Myers Squibb Company Profile
14.1.2 Bristol-Myers Squibb Biological Drugs Product Specification
14.1.3 Bristol-Myers Squibb Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Eli Lilly
14.2.1 Eli Lilly Company Profile
14.2.2 Eli Lilly Biological Drugs Product Specification
14.2.3 Eli Lilly Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Takeda
14.3.1 Takeda Company Profile
14.3.2 Takeda Biological Drugs Product Specification
14.3.3 Takeda Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Pfizer
14.4.1 Pfizer Company Profile
14.4.2 Pfizer Biological Drugs Product Specification
14.4.3 Pfizer Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Amgen
14.5.1 Amgen Company Profile
14.5.2 Amgen Biological Drugs Product Specification
14.5.3 Amgen Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 F. Hoffmann-La Roche
14.6.1 F. Hoffmann-La Roche Company Profile
14.6.2 F. Hoffmann-La Roche Biological Drugs Product Specification
14.6.3 F. Hoffmann-La Roche Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Johnson & Johnson
14.7.1 Johnson & Johnson Company Profile
14.7.2 Johnson & Johnson Biological Drugs Product Specification
14.7.3 Johnson & Johnson Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Merck
14.8.1 Merck Company Profile
14.8.2 Merck Biological Drugs Product Specification
14.8.3 Merck Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Abbott Laboratories
14.9.1 Abbott Laboratories Company Profile
14.9.2 Abbott Laboratories Biological Drugs Product Specification
14.9.3 Abbott Laboratories Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Baxter
14.10.1 Baxter Company Profile
14.10.2 Baxter Biological Drugs Product Specification
14.10.3 Baxter Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Novartis
14.11.1 Novartis Company Profile
14.11.2 Novartis Biological Drugs Product Specification
14.11.3 Novartis Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Biogen
14.12.1 Biogen Company Profile
14.12.2 Biogen Biological Drugs Product Specification
14.12.3 Biogen Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 GlaxoSmithKline
14.13.1 GlaxoSmithKline Company Profile
14.13.2 GlaxoSmithKline Biological Drugs Product Specification
14.13.3 GlaxoSmithKline Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Biological Drugs Market Forecast (2022-2027)
15.1 Global Biological Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Biological Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Biological Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Biological Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Biological Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Biological Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Biological Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Biological Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Biological Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Biological Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Biological Drugs Price Forecast by Type (2022-2027)
15.4 Global Biological Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Biological Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
